Elan Reports First Quarter 2007 Financial Results
PharmaLive.com (press release) - Newtown,PA,USA
Mr. Cooke added, "Revenue growth reflects the solid performance of Tysabri driven by the approximately 12500 patients who have signed up for therapy, ...
See all stories on this topic

Elan leans on ISEQ losers
Ireland Online - Dublin,Ireland
Shares at pharmaceutical company Elan tumbled 6% today after sales of its multiple sclerosis drug Tysabri came below expectations. ...
See all stories on this topic

Elan Q1 loss doubled but Tysabri keeps on track
Reuters - USA
Elan said global sales of the Tysabri MS treatment developed with US partner Biogen Idec (BIIB.O: Quote, Profile, Research) were $48.4 million in the first ...
See all stories on this topic

Morning business - Apr 24
RTE.ie - Ireland
ELAN'S TYSABRI NUMBERS UP 30% - Elan has just reported results for the first three months of the financial year. It reported increased losses, but revenues ...
See all stories on this topic